SCIVISION BIOTECH INC.

Press Releases SciVision Biotech Inc.

Equities

1786

TW0001786002

End-of-day quote Taiwan S.E. Other stock markets 23:00:00 18/06/2024 BST			5-day change	1st Jan Change
126 ^TWD	-1.18%		+9.57%	+62.37%

05-10	Scivision Biotech Inc.'s Product, One-Injection Typehyaluronic Acid Synovial Fluid Supplement"Hyajoint Plus"Has Obtained Medical Device License	CI
05-09	SciVision Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

SciVision Biotech : Announcement of the approval for recordation being granted by FSC on extended offering period of the second domestic unsecured convertible bonds	15/08/22	PU
SciVision Biotech : Announcement of the approval for recordation being granted by FSC on extended offering period of the second domestic unsecured convertible bonds For 3 Months	11/08/22	PU
SciVision Biotech : Announcement of board meeting approved the consolidated financial statements for the second quarter of 2022	03/08/22	PU
SciVision Biotech : Announcement of the company's financial officer, accounting officer and corporate governance officer approved by Board of Directors.	29/06/22	PU
SciVision Biotech : Announce the record date for cash dividend	29/06/22	PU
SciVision Biotech : Announcement the Important Resolutions in 2022 Annual General Meeting of Shareholders	29/06/22	PU
SciVision Biotech : The Company’s Product, hyaluronic acid Flexotron Forte (1%) has obtained medical device license.	09/06/22	PU
SciVision Biotech : The The Company’s Product, hyaluronic acid three-injection linear intra-articular implant, Flexotron Plus (2%) has obtained medical device license.	26/05/22	PU
SciVision Biotech : Board of Directors approved the convening of the 2022 Annual Shareholders' Meeting	23/03/22	PU
SciVision Biotech : The Company's Board of Directors resolved the dividend distributions	23/03/22	PU
SciVision Biotech : The Company's 2021 consolidated financial statements have been approved by the Board of Directors	23/03/22	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Securing my Investments

fermer